By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Navidea Biopharmaceuticals 

425 Metro Place Northurt
Suite 400
Dublin  Ohio  43017  U.S.A.
Phone: 614-793-7500 Fax: 614 793 7520


Medical Device

Company News
European Commission (EC) Approves Navidea Biopharmaceuticals (NAVB)’s Sentinel Lymph Node Detection Agent Lymphoseek® 11/20/2014 9:11:32 AM
Navidea Biopharmaceuticals (NAVB) Receives $1.1Million PDUFA Filing Fee Refund For Award Of Orphan Drug Status; Platinum Partners Reaffirms Commitment To Line Of Credit 11/11/2014 10:42:32 AM
Navidea Biopharmaceuticals (NAVB) Announces Third Quarter 2014 Financial Results 11/6/2014 11:16:19 AM
Navidea Biopharmaceuticals (NAVB) Announces Scientific Presentations Of Results From Lymphoseek® Studies At The European Association Of Nuclear Medicine And European Society Of Surgical Oncology Meetings 10/30/2014 10:08:10 AM
Navidea Biopharmaceuticals (NAVB) To Announce Third Quarter 2014 Financial Results On November 6, 2014 10/29/2014 9:08:20 AM
FDA Approves Expanded Use Of Navidea Biopharmaceuticals (NAVB)’s Lymphoseek® For Lymphatic Mapping In Solid Tumors 10/15/2014 10:59:40 AM
Navidea Biopharmaceuticals (NAVB) Brings In A New CEO 10/15/2014 6:47:34 AM
Navidea Biopharmaceuticals (NAVB) To Participate In The BTIG Emerging Technologies In Healthcare Diagnostics Investor Conference September 30th 9/30/2014 9:42:25 AM
Navidea Biopharmaceuticals (NAVB)’s Lymphoseek® Recommended By CHMP For European Approval In Sentinel Lymph Node Detection For Melanoma, Breast And Certain Head And Neck Cancers 9/26/2014 8:15:55 AM
Navidea Biopharmaceuticals (NAVB) Awarded $1.67M Fast Track National Institutes of Health (NIH) SBIR Grant For Evaluation Of Lymphoseekв In Cervical Cancer 9/23/2014 11:28:01 AM